methylprednisolone has been researched along with molsidomine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mueller, AR; Neuhaus, P; Nüssler, AK; Nüssler, NC; Platz, KP; Radke, C; Schirmeier, A; Schmitz, V; Seehofer, D | 1 |
| Mueller, AR; Neuhaus, P; Nüssler, AK; Nüssler, NC; Platz, KP; Radke, C; Schirmeier, A; Stange, B; Warnecke, HB | 1 |
| Häusler, M; Heckert, C; Lobeck, H; Müller, AR; Neuhaus, P; Platz, KP | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
6 other study(ies) available for methylprednisolone and molsidomine
| Article | Year |
|---|---|
L-arginine application improves graft morphology and mucosal barrier function after small bowel transplantation.
Topics: Animals; Arginine; Biomarkers; Hyaluronan Receptors; Hyaluronic Acid; Interleukin-1; Interleukin-6; Intestinal Mucosa; Intestine, Small; Laminin; Male; Methylprednisolone; Molsidomine; Organ Preservation; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous; Transplantation, Isogeneic; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2000 |
The combined treatment with L-arginine and methylprednisolone improves graft morphology and mucosal barrier function.
Topics: Animals; Arginine; Graft Survival; Intestinal Mucosa; Intestine, Small; Methylprednisolone; Molsidomine; Rats; Rats, Inbred Lew; Reperfusion Injury; Transplantation, Isogeneic; Vasodilator Agents | 2002 |
[L-arginine administration improves mucosal structure in the early phase of reperfusion of small intestine transplants].
Topics: Animals; Anti-Inflammatory Agents; Arginine; Drug Therapy, Combination; Intestinal Mucosa; Intestine, Small; Methylprednisolone; Molsidomine; Premedication; Rats; Rats, Inbred Lew; Reperfusion Injury; Vasodilator Agents | 1998 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |